Previous 10 | Next 10 |
OPKO Health, Inc. (OPK) Q4 2022 Earnings Conference Call February 23, 2023, 16:30 ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman & CEO Elias Zerhouni - President & Vice Chairman Steven Rubin - EVP, Administration &am...
OPKO Health press release ( NASDAQ: OPK ): Q4 GAAP EPS of -$0.11 in-line. Revenue of $185.4M (-53.8% Y/Y) beats by $17.19M . Pharmaceuticals: Revenue from products in the fourth quarter of 2022 increased to $37.9 million from $35.3 million in the fourth quarter of 2021, dr...
MIAMI, Feb. 23, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2022. Business highlights include the following: Sales are underway by Pfizer for NGENLA® (somatrogon) in 15 co...
MIAMI, Feb. 16, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2022 after the close of the U.S. financial markets on Thursday, February 23, 2023. OPKO’s senior management will provide a bu...
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings PR Newswire CINtec ® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, N.J. , Feb. 9, 2023 /P...
MIAMI, Jan. 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 41 st Annual J.P. Morgan Healthcare Conference being held January 9-12, 2023 at the Westin St. Francis in San Francisco. Management will be hosting one-on-...
Summary OPKO Health Inc. shares get a strong sell rating from us for its own failing financial health and collapsing price. The company benefited from COVID-19 with strong revenue in 2020 and 2021 for its BioReference testing segment but it did not last. The optimism of its octogena...
Image source: The Motley Fool. Opko Health (NASDAQ: OPK) Q3 2022 Earnings Call Nov 08, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Opko Health (OPK) Q3 2022 Earnings Call Transcript
OPKO Health, Inc. (OPK) Q3 2022 Earnings Conference Call November 08, 2022 04:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Phillip Frost - Chairman and Chief Executive Officer Adam Logal - SVP and Chief Financial Officer Jon Cohen - SV...
OPKO Health ( NASDAQ: OPK ) is down 5% in after-hours trading after its Q3 2022 results missed on the top and bottom lines . In the quarter, the company swung to a net loss of $86.1M from net income of $28.7M in the prior-year period (-$0.11 per share, basic and di...
News, Short Squeeze, Breakout and More Instantly...
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock. Under the repurchase program, OPKO may repurchase shares of its common ...
MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by OPKO’s profit share payments from Pfizer received pursuant to its license agreement relat...
NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner PR Newswire New Marketing Partner to Support the Expanded Sales of OPKO-Branded Products Throughout China on Additi...